Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial.

Saved in:
Bibliographic Details
Title: Plasma Biomarkers Associated with Clinical Outcomes of FOLFIRI Plus Ramucirumab in RAS Wild-Type Metastatic Colorectal Cancer: The JACCRO CC-16AR Trial.
Authors: Sunakawa Y; Department of Clinical Oncology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan. y.suna0825@gmail.com., Yasui H; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan., Shiozawa M; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan., Takeda H; Department of Clinical Oncology, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan., Akazawa N; Department of Gastroenterological Surgery, Sendai City Medical Center Sendai Open Hospital, Sendai, Japan., Sagawa T; Department of Gastroenterology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan., Shiraishi K; Department of Medical Oncology, NHO Nagoya Medical Center, Nagoya, Japan., Kyogoku T; Department of Surgery, Kobe City Nishi-Kobe Medical Center, Kobe, Japan., Mine T; Department of Clinical Oncology, Nagasaki Harbor Medical Center, Nagasaki, Japan., Yuasa Y; Department of Gastrointestinal Surgery, Tokushima Red Cross Hospital, Tokushima, Japan., Watanabe T; Department of Surgery, Japanese Red Cross Society Himeji Hospital, Himeji, Japan.; Department of Surgery, Tokushima Municipal Hospital, Tokushima, Japan., Kinjo T; Division of Digestive and General Surgery, University of the Ryukyus, Ginowan, Japan., Okita Y; Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan., Okuyama H; Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan., Yuki S; Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan., Miyakawa K; Sysmex Corporation, Kobe, Japan., Kobara A; Sysmex Corporation, Kobe, Japan., Yanaka S; G&G SCIENCE CO., LTD., Fukushima, Japan., Abe Y; G&G SCIENCE CO., LTD., Fukushima, Japan., Ichikawa W; Division of Medical Oncology, Showa Medical University Fujigaoka Hospital, Yokohama, Japan., Fujii M; Japan Clinical Cancer Research Organization, Tokyo, Japan., Tsuji A; Department of Clinical Oncology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
Source: Targeted oncology [Target Oncol] 2026 May 20. Date of Electronic Publication: 2026 May 20.
Publication Type: Journal Article
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1776-260X
DOI:10.1007/s11523-026-01223-2